Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats

References

• Bowles NP, Thosar SS, Herzig MX., et al. 2018. Chronotherapy for hypertension. J Curr. Hypertens. Rep. 20:97–123.
   PubMed Web of Science ®Google Scholar
• Braun MC, Herring SM, Gokul N, Monita M, Bell R, Hicks MJ, Wenderfer SE, Doris PA. 2013. Hypertensive renal disease: susceptibility and resistance in inbred hypertensive rat lines. J Hypertens. 31:2050–2059.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, Nishio T, Yoshida A, Kimura G. 2008. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens. 26:583–588.
   PubMed Web of Science ®Google Scholar
• Gabb GM, Mangoni AA, Anderson CS, Cowley D, Dowden JS, Golledge J, Hankey GJ, Howes FS, Leckie L, Perkovic V. 2017. Guideline for the diagnosis and management of hypertension in adults - 2016. Med J Aust. 205:85.
   Web of Science ®Google Scholar
• Giles TD, Thomas Alessi MD, Purkayastha D, Zappe D. 2012. Comparative efficacy of Aliskiren/Valsartan vs Valsartan in nocturnal dipper and nondipper hypertensive patients: A pooled analysis. J Clin Hypertens. 14:299–306.
   Web of Science ®Google Scholar
• Gordon RD, Wolfe LK, Island DP, Liddle GW. 1966. A diurnal rhythm in plasma renin activity in man. J Clin Invest. 45:1587–1592.
   PubMed Web of Science ®Google Scholar
• Griggs CA, Malm SW, Jaime-Frias R, Smith CL. 2018. Valproic acid disrupts the oscillatory expression of core circadian rhythm transcription factors. Toxicol Appl Pharmacol. 339:110–120.
   PubMed Web of Science ®Google Scholar
• Herichova I, Zsoldosova K, Vesela A, Zeman M. 2014. Effect of angiotensin II infusion on rhythmic clock gene expression and local renin-angiotensin system in the aorta of Wistar rats. Endocr Regul. 48:144–151.
   PubMedGoogle Scholar
• Hermida R, Ayala D, Mojón A, Fernández J. 2013a. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the “normotensive non-dipper” paradox. Chronobiol Int. 30:87–98.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. 2007. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev. 59:923–939.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Artemio M, Smolensky MH, Fabio F, Francesco P. 2013b. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int. 30:280–314.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH. 2018. Hypertension: new perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk. Eur J Clin Invest. 48. doi:10.1111/eci.12909.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. 2013. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int. 30:280–314.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR. 2011. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: Improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int. 28:601–610.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, Fernandez JR, Mojon A, Portaluppi F. 2016. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 39:277–292.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, Mojon A, Fernandez JR, Crespo JJ, Moya A, Rios MT, Portaluppi F. 2013c. Chronotherapy improves blood pressure control and reduces vascular risk in CKD. Nat Rev Nephrol. 9:358–368.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Moyá A, Ayala DE. 2015. Ambulatory blood pressure monitoring in diabetes for the assessment and control of vascular risk. Endocrinol Nutr. 62:400–410.
   PubMedGoogle Scholar
• Hilfenhaus M. 1976. Circadian rhythm of the renin-angiotensin-aldosterone system in the rat. Arch Toxicol. 17:305–316.
   Google Scholar
• Horwitz LD, Fennessey PV, Shikes RH, Kong Y. 1994. Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion. Circulation. 89:1792–1801.
   PubMed Web of Science ®Google Scholar
• Hughes ME, Hogenesch JB, Kornacker K. 2010. JTK_CYCLE: an efficient nonparametric algorithm for detecting rhythmic components in genome-scale data sets. J Biol Rhythms. 25:372–380.
   PubMed Web of Science ®Google Scholar
• Kala R, Fyhrquist F, Eisalo A. 1973. Diurnal variation of plasma angiotensin II in man. Scand J Clin Lab Invest. 31:363–365.
   PubMed Web of Science ®Google Scholar
• Kario K, Hoshide S, Uchiyama K, Yoshida T, Okazaki O, Noshiro T, Aoki H, Mizuno H, Matsumoto Y. 2016. Dose timing of an angiotensin II receptor blocker/calcium channel blocker combination in hypertensive patients with paroxysmal atrial fibrillation. J Clin Hypertens. 18:1036–1044.
   Web of Science ®Google Scholar
• Klimas J, Stankovicova T, Kyselovic J, Bacharova L. 2008. Prolonged QT interval is associated with blood pressure rather than left ventricular mass in spontaneously hypertensive rats. Clin Exp Hypertens. 30:475–485.
   PubMed Web of Science ®Google Scholar
• Koopman MG, Koomen GC, Van Acker BA, Arisz L. 1994. Urinary sodium excretion in patients with nephrotic syndrome, and its circadian variation. Atherosclerosis. 87:109.
   Google Scholar
• Lemmer B, Witte K, Enzminger H, Schiffer S, Hauptfleisch S. 2003. Transgenic TGR(mREN2)27 rats as a model for disturbed circadian organization at the level of the brain, the heart, and the kidneys. Chronobiol Int. 20:711–738.
   PubMed Web of Science ®Google Scholar
• Lemmer B, Witte K, Schanzer A, Findeisen A. 2000. Circadian rhythms in the renin-angiotensin system and adrenal steroids may contribute to the inverse blood pressure rhythm in hypertensive tgr(mren-2)27 rats. Chronobiol Int. 17:645–658.
   PubMed Web of Science ®Google Scholar
• Li T, Yu B, Liu Z, Li J, Ma M, Wang Y, Zhu M, Yin H, Wang X, Fu Y, et al. 2018. Homocysteine directly interacts and activates the angiotensin II type I receptor to aggravate vascular injury. Nat Commun. 9:11.
   PubMed Web of Science ®Google Scholar
• Mascolo A, Sessa M, Scavone C, De Angelis A, Vitale C, Berrino L, Rossi F, Rosano G, Capuano A. 2017. New and old roles of the peripheral and brain renin-angiotensin-aldosterone system (RAAS): focus on cardiovascular and neurological diseases. Int J Cardiol. 227:734–742.
   PubMed Web of Science ®Google Scholar
• Miller AJ, Arnold AC. 2018. The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clin Auton Res. doi:10.1007/s10286-018-0572-5
   PubMed Web of Science ®Google Scholar
• Moore WM Jr, Bunt TJ, Hermann GD, Fogarty TJ. 1988. Assessment of transmural force during application of vascular occlusive devices. J Vasc Surg. 8:422–427.
   PubMed Web of Science ®Google Scholar
• Naito Y, Tsujino T, Masuyama T. 2014. [Circadian variations of the renin-angiotensin-aldosterone system]. Nihon Rinsho Jpn J Clin Med. 72:1381.
   PubMedGoogle Scholar
• Naito Y, Tsujino T, Matsumoto M, Okuda S, Sakoda T, Ohyanagi M, Masuyama T. 2009. The mechanism of distinct diurnal variations of renin-angiotensin system in aorta and heart of spontaneously hypertensive rats. Clin Exp Hypertens. 31:625.
   PubMed Web of Science ®Google Scholar
• Np B, Ss T, Mx H, Sa S. 2018. Chronotherapy for Hypertension. Curr Hypertens Rep. 20:97.
   PubMed Web of Science ®Google Scholar
• Qian Y, Liu Y, Tang H, Zhou W, Jiang L, Li Y, Li N, Li M, Xiao X. 2013. Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease. J Renin Angiotensin Aldosterone Syst. 14:204–211.
   PubMed Web of Science ®Google Scholar
• Rahman A, Hasan AU, Nishiyama A, Kobori H. 2018. Altered Circadian Timing System-Mediated Non-Dipping Pattern of Blood Pressure and Associated Cardiovascular Disorders in Metabolic and Kidney Diseases. Int J Mol Sci. 19:400–421.
   Web of Science ®Google Scholar
• Roush G, Fagard R, Salles G, Pierdomenico S, Reboldi G, Verdecchia P, Eguchi K, Kario K, Polonia J, Sierra ADL. 2014. Prognostic impact of clinic, daytime, and nighttime systolic blood pressure in 9 cohorts of 13,843 patients with hypertension: systematic review and meta-analysis. J Am Soc Hypertens. 8:e59–e59.
   Google Scholar
• Satou R, Penrose H, Navar LG. 2018. Inflammation as a regulator of the renin-angiotensin system and blood pressure. Curr Hypertens Rep. 20:100.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Schmidt ST, Riemer T, Dechend R, Hagedorn I, Senges J, Messerli FH, Zeymer U. 2014. disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatmentnovelty and significance. Hypertension. 64:1067–1072.
   PubMed Web of Science ®Google Scholar
• Smolensky M, Hermida R, Portaluppi F. 2017. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 33:4–16.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. 2010. Administration–time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 15:173–180.
   PubMed Web of Science ®Google Scholar
• Sulli G, Manoogian ENC, Taub PR, Panda S. 2018. Training the circadian clock, clocking the drugs, and drugging the clock to prevent, manage, and treat chronic diseases. Trends Pharmacol Sci. 39:812–827.
   PubMed Web of Science ®Google Scholar
• Te RL, van Esch JH, Roks AJ, van Den Meiracker AH, Danser AH. 2015. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res. 116:960.
   PubMed Web of Science ®Google Scholar
• Vaja V, Ochodnicky P, Krenek P, et al. 2009. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats. Eur J Pharmacol. 619:85–91.
   PubMed Web of Science ®Google Scholar
• Vaja V, Ochodnicky P, Krenek P, Klimas J, Bajuszova Z, Kyselovic J. 2009. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats. Eur J Pharmacol. 619:85–91.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang J, Liu X, Li C, Ye Z, Peng H, Chen Z, Lou T. 2013. Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern. J Clin Hypertens (Greenwich). 15:48–54.
   PubMedGoogle Scholar